Skandinaviska Enskilda Banken (SEB)’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-61,744
Closed -$2.98M 877
2025
Q2
$2.98M Hold
61,744
0.01% 517
2025
Q1
$3.42M Buy
+61,744
New +$3.34M 0.02% 489
2021
Q1
Sell
-44,500
Closed -$2.16M 1190
2020
Q4
$2.16M Sell
44,500
-12,900
-22% -$636K 0.01% 623
2020
Q3
$2.88M Sell
57,400
-2,300
-4% -$118K 0.02% 465
2020
Q2
$3.05M Sell
59,700
-26,000
-30% -$1.26M 0.02% 451
2020
Q1
$3.75M Buy
+85,700
New +$4.1M 0.04% 336

Other funds holding SNY

Skandinaviska Enskilda Banken (SEB)'s SNY Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Sanofi (SNY) in Q3 2025, closing a stake of 61,744 shares — an estimated $2.98M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in SNY in Q1 2020 and held it in 6 quarters. The position peaked at $3.75M in Q1 2020. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 61,744 Sanofi shares in Q3 2025, an estimated $2.98M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Sanofi in Q1 2020 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Sanofi position peaked at $3.75M in Q1 2020.
  • 712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.